Also stolen from ALS.net interesting tidbit.
Acceleron, in Cambridge, Massachusetts, will begin safety trials this year for its myostatin treatment, ACE-031, said Steven Ertel, vice president of corporate development. Acceleron has reported that rodents given the substance had a 60 percent increase in muscle growth and primates, at least 10 percent.
Nonetheless, participants in sports are following the development of myostatin inhibitors. Lee, the Johns Hopkins School of Medicine molecular scientist, recalls putting down a test tube one day about two years ago to take a phone call from a Brazilian bodybuilder who had e-mailed for weeks with questions about the substances.
I was explaining that we were still in the testing phases and that a drug Wyeth has in trials, and he interrupted me and said, `MYO-029?''' Lee said during an interview at his laboratory.He said, `I have some right here. I just want to know if it's safe to take.'''
I warned him against taking something that hadn't been thoroughly tested,'' Lee said.It was a shocking conversation.''